Melanoma (Skin Cancer)

Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions

Superparamagnetic Iron Oxide for Sentinel Lymph Node Localization in Patients With Cutaneous Melanoma, a Randomized Phase III Multi-center Non- Inferiority Trial: MagMen-II

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma

Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA)

NO Re-excision MelanomA - NORMA 2

ctDNA for Risk Stratification in Melanoma

Neoadjuvant Pucotenlimab Combined With Lenvatinib and Temozolomide in Resectable Stage IIB/III Acral Melanoma

A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks

A Phase II Clinical Trial on Neo-adjuvant Pembrolizumab in Patients With pT3b-T4a/b cN0M0 Melanoma.

PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor

Investigating Real-Time Immunotherapy Symptoms Study

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care

Using an Artificial Intelligence Medical Device to Help Primary Care Practitioners Identify and Manage Skin Conditions (Tumor, Inflammatory, and Infectious Diseases) in Adult Patients at Pozuelo and Majadahonda Health Centers

Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors